Prophylactic treatment of severe factor X deficiency with prothrombin complex concentrate

Haemophilia

Volumn 7, Issue 2, 2001, Pages 220-223

  Kouides, P A ^b,c   Kulzer, L ^a  

^a Mary M Gooley Hemophilia Center   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^c ROCHESTER GENERAL HOSPITAL   (United States)

Author keywords

Factor X deficiency; Prophylactic treatment; Prothrombin complex concentrate

Indexed keywords

BLOOD CLOTTING FACTOR 9 COMPLEX; IRON; PROTHROMBIN COMPLEX;

ADULT; ANEMIA; ANKLE; ARTHROPATHY; ARTICLE; BLEEDING; BLOOD CLOTTING FACTOR 10 DEFICIENCY; CASE REPORT; DISEASE SEVERITY; DRUG HALF LIFE; DRUG INFUSION; EPISTAXIS; ERYTHROCYTE TRANSFUSION; HEMARTHROSIS; HOME CARE; HUMAN; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; SOFT TISSUE; THROMBOSIS; TREATMENT OUTCOME; X RAY;

ADOLESCENT; BLOOD COAGULATION FACTORS; FACTOR X DEFICIENCY; HEMORRHAGE; HOME INFUSION THERAPY; HUMANS; MALE; QUALITY OF LIFE;

EID: 0035077839     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.2001.00485.x     Document Type: Article

References (17)

1. Inherited factor X deficiency: Molecular genetics and pathophysiology
2. Practice
3. The structural gene for human coagulation factor X is located on chromosome 13q34
4. Congenital factor X deficiency: Spectrum of bleeding symptoms in 32 Iranian patients
5. Replacement therapy for congenital factor X deficiency
6. Severe congenital factor X deficiency with intracranial haemorrhage
7. Prevention of recurrent intracranial hemorrhage in a factor X-deficient infant
8. Thrombogenicity associated with factor IX complex concentrates
9. Thrombogenicity of prothrombin complex concentrates
10. Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B
11. The impact of prophyactic treatment on children with severe haemophilia
12. A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs
13. Results of secondary prophylaxis in children with severe hemophilia
14. Prophylaxis for hemophilia: State of the art or state of confusion?
15. Virus safety of prothrombin complex concentrates and factor IX concentrates
16. Rational, high quality laboratory monitoring before, during, and after infusion of prothrombin complex concentrates
17. Hemophilia and related conditions